- Home
- CLPS vs GRCE Comparison
CLPS vs GRCE Comparison
Compare CLPS & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- GRCE
- Stock Information
- Founded
- CLPS 2005
- GRCE 2002
- Country
- CLPS Hong Kong
- GRCE United States
- Employees
- CLPS N/A
- GRCE N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- GRCE
- Sector
- CLPS Technology
- GRCE
- Exchange
- CLPS Nasdaq
- GRCE NYSE
- Market Cap
- CLPS 33.9M
- GRCE 32.1M
- IPO Year
- CLPS 2018
- GRCE N/A
- Fundamental
- Price
- CLPS $1.18
- GRCE $2.29
- Analyst Decision
- CLPS
- GRCE Strong Buy
- Analyst Count
- CLPS 0
- GRCE 1
- Target Price
- CLPS N/A
- GRCE $12.00
- AVG Volume (30 Days)
- CLPS 19.1K
- GRCE 34.0K
- Earning Date
- CLPS 03-05-2025
- GRCE 02-13-2025
- Dividend Yield
- CLPS 11.11%
- GRCE N/A
- EPS Growth
- CLPS N/A
- GRCE N/A
- EPS
- CLPS N/A
- GRCE N/A
- Revenue
- CLPS $153,816,045.00
- GRCE N/A
- Revenue This Year
- CLPS N/A
- GRCE N/A
- Revenue Next Year
- CLPS N/A
- GRCE N/A
- P/E Ratio
- CLPS N/A
- GRCE N/A
- Revenue Growth
- CLPS 5.81
- GRCE N/A
- 52 Week Low
- CLPS $0.68
- GRCE $2.13
- 52 Week High
- CLPS $1.70
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- CLPS 45.65
- GRCE N/A
- Support Level
- CLPS $1.17
- GRCE N/A
- Resistance Level
- CLPS $1.21
- GRCE N/A
- Average True Range (ATR)
- CLPS 0.06
- GRCE 0.00
- MACD
- CLPS -0.00
- GRCE 0.00
- Stochastic Oscillator
- CLPS 34.69
- GRCE 0.00
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.